A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD

Study Site 14, Richmond

Study Site 09, Durham

Study Site 10, Athens

Study Site 01, Gainesville

Study Site 15, Orlando

Study Site 11, Ocoee

Study Site 03, Indianapolis

Study Site 13, Rapid City

Study Site 07, Marrero

Study Site 05, West Monroe

Study Site 06, Arlington

Study Site 04, San Antonio

Study Site 12, San Antonio

Study Site 02, Los Angeles

Study Site 08, Berlin